FR2327797B2 - - Google Patents

Info

Publication number
FR2327797B2
FR2327797B2 FR7630804A FR7630804A FR2327797B2 FR 2327797 B2 FR2327797 B2 FR 2327797B2 FR 7630804 A FR7630804 A FR 7630804A FR 7630804 A FR7630804 A FR 7630804A FR 2327797 B2 FR2327797 B2 FR 2327797B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7630804A
Other languages
French (fr)
Other versions
FR2327797A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University
Original Assignee
Ohio State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University filed Critical Ohio State University
Publication of FR2327797A2 publication Critical patent/FR2327797A2/fr
Application granted granted Critical
Publication of FR2327797B2 publication Critical patent/FR2327797B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0006Contraceptive vaccins; Vaccines against sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/5555Muramyl dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6081Albumin; Keyhole limpet haemocyanin [KLH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7630804A 1975-10-14 1976-10-13 Modification antigene de polypeptides Granted FR2327797A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62203175A 1975-10-14 1975-10-14

Publications (2)

Publication Number Publication Date
FR2327797A2 FR2327797A2 (fr) 1977-05-13
FR2327797B2 true FR2327797B2 (he) 1979-03-02

Family

ID=24492662

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7630804A Granted FR2327797A2 (fr) 1975-10-14 1976-10-13 Modification antigene de polypeptides

Country Status (13)

Country Link
JP (1) JPS5251017A (he)
AU (1) AU513558B2 (he)
BE (1) BE847243R (he)
DE (1) DE2646223A1 (he)
FR (1) FR2327797A2 (he)
GB (1) GB1567764A (he)
HK (1) HK10883A (he)
IE (1) IE44541B1 (he)
MY (1) MY8500808A (he)
NL (1) NL7611212A (he)
NZ (1) NZ182272A (he)
SG (1) SG63582G (he)
ZA (1) ZA766143B (he)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
EP0326111A3 (en) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptide derivatives rendered immunogenic when administered with alum as an adjuvant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1467782A1 (de) * 1963-07-17 1968-12-12 Behringwerke Ag Verfahren zur Herstellung von kuenstlichen Antigenen
CH622426A5 (en) * 1973-05-07 1981-04-15 Univ Ohio Contraceptive composition

Also Published As

Publication number Publication date
FR2327797A2 (fr) 1977-05-13
HK10883A (en) 1983-03-24
GB1567764A (en) 1980-05-21
IE44541L (en) 1977-04-14
IE44541B1 (en) 1981-12-30
DE2646223C2 (he) 1990-09-27
AU513558B2 (en) 1980-12-11
BE847243R (fr) 1977-04-13
ZA766143B (en) 1978-05-30
JPS5251017A (en) 1977-04-23
AU1858476A (en) 1978-04-20
SG63582G (en) 1983-09-09
NZ182272A (en) 1985-03-20
MY8500808A (en) 1985-12-31
NL7611212A (nl) 1977-04-18
DE2646223A1 (de) 1977-04-28

Similar Documents

Publication Publication Date Title
JPS5192380A (he)
AU496168B2 (he)
CH600132A5 (he)
CH598420A5 (he)
BE826796A (he)
BE846112A (he)
BG21073A1 (he)
CH601099A5 (he)
BG22245A1 (he)
BG22301A1 (he)
BG22558A1 (he)
BG22616A1 (he)
BG22913A1 (he)
BG23412A1 (he)
CH579442A5 (he)
CH581877A5 (he)
CH583647A5 (he)
CH586518A5 (he)
CH586541A5 (he)
CH589383A5 (he)
CH590391A5 (he)
CH591438A5 (he)
CH592404A5 (he)
CH592890A5 (he)
CH593320A5 (he)